1. Institute of Clinical Pharmacology (Q.H., Y.-S.Z., X.-P.C., J.C., H.-H.Z., J.-Y.Y., Z.-Q.L.), Hunan Key Laboratory of Pharmacogenetics, Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, People's Republic of China;
2. Institute of Clinical Pharmacology (Q.H., W.W.), Key Laboratory of Antiinflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei, Anhui 230032, People's Republic of China;
3. Institutes of Hypertension (T.-L.Y.), Hunan 410008, People's Republic of China;
4. Departments of Neurology (B.-S.T.), Hunan 410008, People's Republic of China;
5. Dermatology (X.C.), Xiangya Hospital, Central South University, Changsha, Hunan 410008, People's Republic of China;
6. Integrated Traditional Chinese and Western Medicine (X.H.), Hunan 410008, People's Republic of China;
7. Institute of Endocrinology and Metabolism (X.-H.L.), The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, People's Republic of China;
8. Department of Epidemiology and Biostatistics (P.-C.H.), School of Public Health, Xiangya School of Medicine, Central South University, Changsha, Hunan 410078, People's Republic of China